entertainment -WSS

entertainment

author：entertainment 2025-09-30 19:26:09 - browse：6

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： White House drug shortages task force keeps mum with Congress

leisure time

WSS

FDA approves updated Covid vaccines

What to make of Biden’s latest efforts on cancer research

How housing is health care on Long Island

FDA approves updated Covid vaccines

Genentech weighs delaying cancer therapy after drug pricing law

White House touts steps to stem shortages of cancer treatments

hotspot

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

Wildfire smoke exposes gaps in outdoor worker protections

Faced with fears of OxyContin misuse, sales reps touted its safety

BioMarin wins approval for gene therapy to treat hemophilia A

Regeneron agrees to White House price limits on anti

Jerome Adams on the need for new antivirals for Covid

New weight loss drugs vying to be the next Wegovy or Mounjaro

Medical leaders decry Supreme Court decision on affirmative action

PEPFAR is under serious threat — and so is global health

explore

Where are patients getting their prescriptions for GLP

New Covid vaccine is recommended for everyone 6 months or older

Telehealth for opioid use disorder is lifesaving

Where are patients getting their prescriptions for GLP

Walmart eyes Medicare Advantage provider ChenMed

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

hotspot

hotspot

leisure time

focus